Treatment with the 5-HT3 antagonist tropisetron modulates glucose-induced obesity in mice

International Journal of Obesity

Volumn 33, Issue 12, 2009, Pages 1339-1347

  Weber, S ^a   Volynets, V ^a   Kanuri, G ^a   Bergheim, I ^a   Bischoff, S C ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

Glucose; Serotonin receptor 3; Tropisetron

Indexed keywords

3 HYDROXYBUTYRATE DEHYDROGENASE; FATTY ACID SYNTHASE; GLUCOSE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 2; KETONE BODY; MESSENGER RNA; SEROTONIN 3 ANTAGONIST; SODIUM GLUCOSE COTRANSPORTER; TRIACYLGLYCEROL; TROPISETRON; INDOLE DERIVATIVE; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; FEEDING; GLUCOSE INTAKE; GLUCOSE METABOLISM; INTESTINE MOTILITY; LIVER; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUGAR INTAKE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GASTROINTESTINAL MOTILITY; METABOLISM; PHYSIOLOGY;

ANIMALS; BODY WEIGHT; GASTROINTESTINAL MOTILITY; GLUCOSE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; INDOLES; MICE; MICE, INBRED C57BL; OBESITY; RNA, MESSENGER; SEROTONIN ANTAGONISTS; WEIGHT GAIN;

ANIMALIA; MUS;

EID: 71949131560     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2009.191     Document Type: Article

References (35)

1. Olufadi R, Byrne CD. Clinical and laboratory diagnosis of the metabolic syndrome. J Clin Pathol 2008; 61: 697-706.
2. Astrup A. Dietary management of obesity. JPEN J Parenter Enteral Nutr 2008; 32: 575-577.
3. Gross LS, Li L, Ford ES, Liu S. Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. Am J Clin Nutr 2004; 79: 774-779.
4. Schulze MB, Manson JE, Ludwig DS, Colditz GA, Stampfer MJ, Willett WC et al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004; 292: 927-934.
5. Spitzer L, Rodin J. Effects of fructose and glucose preloads on subsequent food intake. Appetite 1987; 8: 135-145.
6. Brito VB, Folmer V, Soares JC, Silveira ID, Rocha JB. Long-term sucrose and glucose consumption decreases the delta-aminole-vulinate dehydratase activity in mice. Nutrition 2007; 23: 818-826.
7. Lindqvist A, Baelemans A, Erlanson-Albertsson C. Effects of sucrose, glucose and fructose on peripheral and central appetite signals. Regul Pept 2008; 150: 26-32.
8. Bergheim I, Weber S, Vos M, Kramer S, Volynets V, Kaserouni S et al. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 2008; 48: 983-992.
9. Sclafani A. Carbohydrate-induced hyperphagia and obesity in the rat: effects of saccharide type, form, and taste. Neurosci Biobehav Rev 1987; 11: 155-162.
10. Blundell JE, Latham CJ. Serotonergic influences on food intake: effect of 5-hydroxytryptophan on parameters of feeding behaviour in deprived and free-feeding rats. Pharmacol Biochem Behav 1979; 11: 431-437.
11. Simansky KJ, Sisk FC, Vaidya AH, Eberle-Wang K. Peripherally administered alpha-methyl-5-hydroxy-tryptamine and 5-carbox-amidotryptamine reduce food intake via different mechanisms in rats. Behav Pharmacol 1989; 1: 241-246.
12. Sugimoto Y, Yoshikawa T, Yamada J. Effects of peripheral administration of 5-hydroxytryptamine (5-HT) on 2-deoxy-D-glucose-induced hyperphagia in rats. Biol Pharm Bull 2002; 25: 1364-1366.
13. Raybould HE, Glatzle J, Robin C, Meyer JH, Phan T, Wong H et al. Expression of 5-HT3 receptors by extrinsic duodenal afferents contribute to intestinal inhibition of gastric emptying. Am J Physiol Gastrointest Liver Physiol 2003; 284: G367-G372.
14. Zhu JX, Zhu XY, Owyang C, Li Y. Intestinal serotonin acts as a paracrine substance to mediate vagal signal transmission evoked by luminal factors in the rat. J Physiol 2001; 530: 431-442. (Pubitemid 32162331)
15. Savastano DM, Carelle M, Covasa M. Serotonin-type 3 receptors mediate intestinal polycose-and glucose-induced suppression of intake. Am J Physiol Regul Integr Comp Physiol 2005; 288: R1499-R1508.
16. Savastano DM, Covasa M. Intestinal nutrients elicit satiation through concomitant activation of CCK(1) and 5-HT(3) receptors. Physiol Behav 2007; 92: 434-442.
17. Bischoff SC, Mailer R, Pabst O, Weier G, Sedlik W, Li Z et al. Role of serotonin in intestinal inflammation: knockout of serotonin reuptake transporter exacerbates 2,4,6-trinitrobenzene sulfonic acid colitis in mice. Am J Physiol Gastrointest Liver Physiol 2009; 296: G685-G695.
18. Drewnowski A, Bellisle F. Liquid calories, sugar, and body weight. Am J Clin Nutr 2007; 85: 651-661.
19. Malik VS, Schulze MB, Hu FB. Intake of sugar-sweetened beverages and weight gain: a systematic review. Am J Clin Nutr 2006; 84: 274-288.
20. Raben A, Vasilaras TH, Moller AC, Astrup A. Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects. Am J Clin Nutr 2002; 76: 721-729.
21. Kanarek RB, Orthen-Gambill N. Differential effects of sucrose, fructose and glucose on carbohydrate-induced obesity in rats. J Nutr 1982; 112: 1546-1554.
22. Sclafani A, Xenakis S. Sucrose and polysaccharide induced obesity in the rat. Physiol Behav 1984; 32: 169-174.
23. Bravo G, Maswood S. Acute treatment with 5-HT3 receptor antagonist, tropisetron, reduces immobility in intact female rats exposed to the forced swim test. Pharmacol Biochem Behav 2006; 85: 362-368.
24. Nguyen H, Wang H, Le T, Ho W, Sharkey KA, Swain MG. Downregulated hypothalamic 5-HT3 receptor expression and enhanced 5-HT3 receptor antagonist-mediated improvement in fatigue-like behaviour in cholestatic rats. Neurogastroenterol Motil 2008; 20: 228-235.
25. Fuller RW. Serotonin uptake inhibitors: uses in clinical therapy and in laboratory research. Prog Drug Res 1995; 45: 167-204.
26. Wurtman JJ, Wurtman RJ. Fenfluramine and fluoxetine spare protein consumption while suppressing caloric intake by rats. Science 1977; 198: 1178-1180.
27. Ricca V, Mannucci E, di BM, Rizzello SM, Cabras PL, Rotella CM. Sertraline enhances the effects of cognitive-behavioral treatment on weight reduction of obese patients. J Endocrinol Invest 1996; 19: 727-733.
28. Halford JC, Harrold JA, Boyland EJ, Lawton CL, Blundell JE. Serotonergic drugs: effects on appetite expression and use for the treatment of obesity. Drugs 2007; 67: 27-55.
29. Rosenzweig-Lipson S, Zhang J, Mazandarani H, Harrison BL, Sabb A, Sabalski J et al. Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503. Brain Res 2006; 1073-1074: 240-251.
30. Grignaschi G, Invernizzi RW, Fanelli E, Fracasso C, Caccia S, Samanin R. Citalopram-induced hypophagia is enhanced by blockade of 5-HT(1A) receptors: role of 5-HT(2C) receptors. Br J Pharmacol 1998; 124: 1781-1787.
31. Wolf H. Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists. Scand J Rheumatol Suppl 2000; 113: 37-45.
32. Kishi K, Tanaka T, Igawa M, Takase S, Goda T. Sucrase-isomaltase and hexose transporter gene expressions are coordinately enhanced by dietary fructose in rat jejunum. J Nutr 1999; 129: 953-956.
33. Iizuka K, Horikawa Y. ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome. Endocr J 2008; 55: 617-624.
34. Davies MN, O'Callaghan BL, Towle HC. Glucose activates ChREBP by increasing its rate of nuclear entry and relieving repression of its transcriptional activity. J Biol Chem 2008; 283: 24029-24038.
35. Tsatsos NG, Towle HC. Glucose activation of ChREBP in hepatocytes occurs via a two-step mechanism. Biochem Biophys Res Commun 2006; 340: 449-456